Introduced in the country on 14th November 2014, this innovative therapy has revolutionised treatment for conditions like chronic gastrointestinal and liver disorders, Parkinson’s Disease, and Autism Spectrum Disorder
Read More
"The Indian pharmaceutical market for chronic diseases is experiencing significant growth. By leveraging our expertise in chronic therapies and dedication to innovation and brand development, JB Pharma is well-positioned to continue its upward trajectory in the Indian pharmaceutical market." - Dilip Singh Rathore, President-India Business, JB Pharma
Read More
